Hikma Pharmaceuticals Plc ADR (OP: HKMPY )

49.99 UNCHANGED

Streaming Delayed Price Updated: 9:34 AM EST, Dec 24, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hikma Pharmaceuticals Plc ADR

Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production

September 06, 2024

Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally.

Via Benzinga

Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices

August 28, 2024

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and...

Via Benzinga

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape

June 12, 2023

The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat...

Via Benzinga

Friday Markets News

March 25, 2022

Methane leaks in the Permian Basin are 6 times higher than estimates.

Via Talk Markets

Summer Friday

June 25, 2021

The stock market tried for another record after yesterday's late blowout over the infrastructure deal.

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.